Welcome
Support Centre
12 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A randomised controlled trial investigating the efficacy of foot orthoses in rheumatoid arthritis (RA)
Source of recordUK Trials
ISRCTNISRCTN53598448
Date ISRCTN assigned18/07/2002
Local reference number(s)W0542
Public titleA randomised controlled trial investigating the efficacy of foot orthoses in rheumatoid arthritis (RA)
Scientific title
AcronymN/A
Disease/condition/study domainRheumatoid arthritis
Study hypothesisA common rearfoot problem in rheumatoid arthritis is the progressive development of valgus heel deformity. This condition is underdiagnosed and management strategies generally employed at a late stage when secondary features have developed and the deformity is uncorrectable. The mechanical cause of valgus heel deformity is excessive subtalar pronation during the contact phase of gait. Foot orthoses used by podiatrists have been shown to correct pronation but their use has not been formally evaluated in rheumatoid arthritis. The aim of this study is to evaluate the effectiveness of foot orthoses in preventing valgus heel deformity and preventing secondary features.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Current history of bilateral subtalar ± ankle ± talonavicular pain, and valgus heel deformity
2. Normal range of motions was required at the ankle, subtalar and midtarsal joints
3. Passive range of motion testing was used to ensure the valgus heel deformity was correctable with 10 degrees of subtalar joint inversion past neutral
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date11/01/1996
Anticipated end date10/01/2000
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsPatients with RA were randomised to receive custom manufactured rigid foot orthoses under podiatry supervision or enter a control group.

The control group received foot orthoses only when prescribed under normal medical care.
Primary outcome measure(s)Video gait analysis, dynamic load measurements, pain and disability assessment and evaluation of disease status will be mapped for patients over a 60 month period. Appropriate comparative analyses will be made.
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingArthritis Research Campaign
Sponsor nameArthritis Research Campaign (UK)
Sponsor detailsCopeman House
St Mary's Court
St Mary's Gate
Chesterfield
Derbyshire
United Kingdom
S41 7TD
Sponsor emailinfo@arc.org.uk
Sponsor websitehttp://www.arc.org.uk
Contact nameDr James Woodburn
Contact detailsRheumatology & Rehabilitation Research Unit
University of Leeds
School of Medicine
University of Leeds
36 Clarendon Road
Leeds
United Kingdom
LS2 9NZ
Contact telephone+44 (0)113 233 4938
Contact emailmrpjw@leeds.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN53598448
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central